GNPX Press Release: PM Gene Therapy Reverses Hyperglycemia in T2D Mice, 4-Week Complete Rescue, Endoscopic Delivery Potential
Genprex, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $0.75
-6.5% in 7d after detection
Post-detection moves
1h
—
1d
-6.0%
3d
-0.8%
7d
-6.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS